The increased prostate cancer risk in the SELECT study population may indeed be driven by a subset of participants with an inherited polymorphism in Nkx3.1 (rs11781886) that is associated with increased prostate cancer risk [66]. Here, NKX3-1 is linked to prostate carcinoma.